Fecal Microbiota Transplantation Combined with QL1706, Bevacizumab, and XELOX As First-line Treatment for Advanced MSS-type Colon Cancer with Liver Metastasis: Study Protocol for a Prospective, Multi-center, Single-arm Phase II Exploratory Trial
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Iparomlimab/tuvonralimab (Primary) ; Oxaliplatin (Primary)
- Indications Colon cancer; Liver metastases
- Focus Therapeutic Use
- 04 Feb 2025 New trial record